Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone vs sufentanil PCA for postoperative delirium after thoracoscopic lobectomy
ChiCTR2500106826Phase 4Recruiting
- Sponsor
- Jianyang People's Hospital
- Start
- Jul 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative delirium (POD) comparing Oxycodone PCA arm with Sufentanil PCA arm (2 arms). Primary endpoint: Incidence of postoperative delirium within 3 days after surgery. Started Jul 2025; status: recruiting.
02
Drugs
oxycodonesufentanil
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2500106826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106826.